Skip to main
RGEN
RGEN logo

Repligen (RGEN)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Repligen (RGEN) Stock

About Repligen (RGEN)

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.
Market cap$7.1B
Today's volume523.17K
Revenue (TTM)$650.43M
Avg. daily volume850.56K
EBITDA (TTM)$124.55M
Open$126.39
Price / earnings ratio-307.19x
Today's range$125.63 - $128.19
Debt / equity34.43x
52 week range$102.97 - $182.52
5 year debt / equity16.18x
Beta (LTM)1.4x
Interest coverage1x
Dividend & yield$0.00 (0.00%)
Current ratio6.79x
Ex-dividend date
Next earningsJul 29, 2025
Dividend payable date

Repligen Stock Rating

What analysts recommend for RGEN stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 45%
Buy 40%
Hold 15%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jul 01, 2025, the market cap for Repligen stock is $7.11B

The current P/E ratio for Repligen stock is -307.19

The 52-week high for Repligen stock is $182.52. The current Repligen stock price $undefined is 100.00% below its 52-week high

The 52-week low for Repligen stock is $102.97. The current Repligen stock price $undefined has increased 100.00% from its 52-week low

No, the Repligen stock does not pay dividends to its shareholders

The target price for Repligen stock is $163.30 based on the average of what a group of analyst think Repligen stock could be worth at a future date. This is not a prediction by Public.com

How to buy Repligen stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in Repligen stock

    Navigate to the Explore page. Then, type Repligen into the search bar. When you see Repligen stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased Repligen stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Repligen Stock Earnings

The value each RGEN share was expected to gain vs. the value that each RGEN share actually gained.

Repligen (RGEN) reported Q1 2025 earnings per share (EPS) of $0.39, beating estimates of $0.35 by 11.43%. In the same quarter last year, Repligen's earnings per share (EPS) was $0.28. Repligen is expected to release next earnings on 07/29/2025, with an earnings per share (EPS) estimate of $0.39.

Buy Repligen (RGEN) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.